These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22050235)

  • 1. Amelanotic melanoma: a detailed morphologic analysis with clinicopathologic correlation of 75 cases.
    Cheung WL; Patel RR; Leonard A; Firoz B; Meehan SA
    J Cutan Pathol; 2012 Jan; 39(1):33-9. PubMed ID: 22050235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
    de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
    Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.
    Thomas NE; Kricker A; Waxweiler WT; Dillon PM; Busman KJ; From L; Groben PA; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Orlow I; Paine S; Ollila DW; Reiner AS; Luo L; Hao H; Frank JS; Begg CB; Berwick M;
    JAMA Dermatol; 2014 Dec; 150(12):1306-314. PubMed ID: 25162299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features.
    Pizzichetta MA; Talamini R; Stanganelli I; Puddu P; Bono R; Argenziano G; Veronesi A; Trevisan G; Rabinovitz H; Soyer HP
    Br J Dermatol; 2004 Jun; 150(6):1117-24. PubMed ID: 15214897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically amelanotic or hypomelanotic melanoma: Anatomic distribution, risk factors, and survival.
    Wee E; Wolfe R; Mclean C; Kelly JW; Pan Y
    J Am Acad Dermatol; 2018 Oct; 79(4):645-651.e4. PubMed ID: 30241625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and associations of high-mitotic-rate melanoma.
    Shen S; Wolfe R; McLean CA; Haskett M; Kelly JW
    JAMA Dermatol; 2014 Oct; 150(10):1048-55. PubMed ID: 25142970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anorectal amelanotic melanoma.
    Hillenbrand A; Barth TF; Henne-Bruns D; Formentini A
    Colorectal Dis; 2008 Jul; 10(6):612-5. PubMed ID: 17944970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients.
    Quinn MJ; Crotty KA; Thompson JF; Coates AS; O'Brien CJ; McCarthy WH
    Cancer; 1998 Sep; 83(6):1128-35. PubMed ID: 9740077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship.
    Li Q; Murphy M; Ross J; Sheehan C; Carlson JA
    J Cutan Pathol; 2004 Nov; 31(10):633-42. PubMed ID: 15491322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative decreases in tyrosinase, TRP-1, TRP-2, and Pmel 17/silver antigenic proteins from melanotic to amelanotic stages of syngeneic mouse cutaneous melanomas and metastases.
    Orlow SJ; Silvers WK; Zhou BK; Mintz B
    Cancer Res; 1998 Apr; 58(7):1521-3. PubMed ID: 9537258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
    Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
    Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic, misdiagnosis, and survival differences between clinically amelanotic melanomas and pigmented melanomas.
    Strazzulla LC; Li X; Zhu K; Okhovat JP; Lee SJ; Kim CC
    J Am Acad Dermatol; 2019 May; 80(5):1292-1298. PubMed ID: 30654075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological characteristics and prognosis of amelanotic acral melanoma: A comparative study with pigmented acral melanoma.
    Gong HZ; Zheng HY; Li J
    Australas J Dermatol; 2020 Nov; 61(4):358-361. PubMed ID: 32424819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of cytoplasmic p27 expression in human melanoma.
    Chen G; Cheng Y; Zhang Z; Martinka M; Li G
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amelanotic malignant melanoma: two collision tumors presenting as basal cell carcinoma and atypical fibroxanthoma.
    McGregor DH; Cherian R; Romanas MM; Ulusarac O; Mathur SC; Feldman MM
    Ann Clin Lab Sci; 2008; 38(2):157-62. PubMed ID: 18469362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matched analysis of the prognosis of amelanotic and pigmented melanoma in head and neck.
    Guo W; Yin G; Liu H; Duan H; Huang Z; Chen X
    Acta Otolaryngol; 2020 Sep; 140(9):785-788. PubMed ID: 32449432
    [No Abstract]   [Full Text] [Related]  

  • 18. Cutaneous malignant melanoma of the head and neck.
    Fisher SR
    Laryngoscope; 1989 Aug; 99(8 Pt 1):822-36. PubMed ID: 2755292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solar elastosis in cutaneous melanoma.
    Vollmer RT
    Am J Clin Pathol; 2007 Aug; 128(2):260-4. PubMed ID: 17638660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and dermoscopic characteristics of amelanotic melanomas that are not of the nodular subtype.
    Jaimes N; Braun RP; Thomas L; Marghoob AA
    J Eur Acad Dermatol Venereol; 2012 May; 26(5):591-6. PubMed ID: 21585561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.